FREDERICK JENKIN: Open Payments
NPI 1225069123 · LA MESA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,708 in 34 payments from 17 companies in 2025. Trend: 2023 $503 · 2024 $1,252 · 2025 $2,708
Food & beverage: $2,698Education: $9
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $375 |
| BeOne Medicines USA, Inc. | 2 | $282 |
| UCB, Inc. | 2 | $250 |
| Incyte Corporation | 2 | $249 |
| Janssen Biotech, Inc. | 2 | $248 |
| Vanda Pharmaceuticals Inc. | 9 | $166 |
| ACADIA Pharmaceuticals Inc | 4 | $147 |
| Fresenius Kabi USA, LLC | 1 | $143 |
| Alkermes, Inc. | 1 | $126 |
| CSL Behring | 1 | $124 |
Products named: BRUKINSA, VRAYLAR, RYBREVANT, FANAPT, NUPLAZID, Kabiven, LYBALVI, QULIPTA.
Industry payments across CA — which companies pay providers there.
